Welcome to the first participants on the RADAR Study

The NICRF welcomes the first participants of the RADAR Study: Reducing Pathology in Alzheimer’s Disease Through Angiotensis Targeting. The RADAR Trial
Dr Bernadette McGuinness, Principal Investigator within the Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, QUB, is undertaking a Phase II, randomised, double-blind, placebo-control trial to evaluate the effect of Losartan on brain tissue in patients diagnosed with Alzheimer’s Disease.
Read more about the Study here.
Share
Latest News
- Support the COVID Rehabilitation Fund23 April, 2020
- Job Opportunity, NICRF: Band 6, BHSCT post2 January, 2020
- Happy New Year from NICRF2 January, 2020
- Welcome to the first participants of the VR_LV Study, November 201811 December, 2018
- Welcome to the first participants of the MACUSTAR Study, January 20194 December, 2018